TCGX Asia Life Sciences

VC firm · Palo Alto, CA

Verified active in the last 12 months

Venture firm based in Palo Alto, CA. Most recent fund on file: TCGX Asia Life Sciences Fund I, L.P. ($400M offering), filed Jul 2026.

Stages
Seed to Series B
Typical check (est.)
$4M–$12M
Latest fund
$400M · Jul 2026
Last verified activity
Jul 2026

Focus

Biotech & Pharma

Funds and vehicles on SEC file

  • TCGX Asia Life Sciences Fund I, L.P.

    Fund · $400M offering

    Jul 2026

Sources

Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.